Newland Pharmaceutical Co., Ltd. (SHE:301277)
12.31
-0.08 (-0.65%)
Mar 9, 2026, 4:00 PM EDT
16.29% (1Y)
| Market Cap | 4.89B |
| Revenue (ttm) | 670.43M |
| Net Income (ttm) | 123.72M |
| Shares Out | 392.08M |
| EPS (ttm) | 0.32 |
| PE Ratio | 39.51 |
| Forward PE | n/a |
| Dividend | 0.29 (2.32%) |
| Ex-Dividend Date | Apr 16, 2025 |
| Volume | 2,139,740 |
| Average Volume | 2,198,315 |
| Open | 12.24 |
| Previous Close | 12.39 |
| Day's Range | 12.22 - 12.42 |
| 52-Week Range | 10.41 - 18.38 |
| Beta | 0.39 |
| RSI | 46.39 |
| Earnings Date | Mar 20, 2026 |